Physician profile
Christopher Atticus Henry
NPI 1306073044
$9,337.41
in general payments reported to CMS, 2019-2025
36 companies · $1,123 in 2025
The $1,123 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,011 · 2020: $289 · 2021: $530 · 2022: $271 · 2023: $2,030 · 2024: $3,083 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,437 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,800 · Travel and Lodging: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,436.64 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,800.00 |
| Travel and Lodging | $999.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,120.91 | 2021-2025 | Micra, Hawkone, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $1,070.21 | 2019-2025 | Watchman Flx, Watchman Access System, Opticross |
| Medical Device Business Services, INC. | $999.81 | 2023 | Carto 3 |
| Biosense Webster, INC. | $773.69 | 2020-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Novartis Pharmaceuticals Corporation | $630.96 | 2020-2025 | |
| Abbott Laboratories | $488.34 | 2019-2025 | Cardiomems |
| Pfizer INC. | $462.85 | 2019-2025 | |
| Biotronik INC. | $353.73 | 2019-2020 | |
| Amgen INC. | $329.55 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $263.64 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $214.89 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $209.11 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $208.62 | 2019-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $161.62 | 2025 | Assure Wcd |
| Medtronic Vascular, INC. | $161.27 | 2019-2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $120.73 | 2019-2023 | |
| Abiomed | $79.95 | 2023-2024 | Impella |
| Kiniksa Pharmaceuticals International, Plc | $76.11 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $70.54 | 2022-2023 | Optimizer |
| Lundbeck LLC | $66.23 | 2019-2020 | |
| Teleflex LLC | $50.91 | 2019-2025 | Trapliner |
| Sanofi-Aventis U.S. LLC | $47.65 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $46.72 | 2022-2023 | Brilinta, Andexxa |
| Altathera Pharmaceuticals LLC | $43.74 | 2025 | Sotalol Hydrochloride |
| Regeneron Healthcare Solutions, INC. | $43.51 | 2019 | |
| Stryker Corporation | $41.48 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiva Medical, INC. | $34.75 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $24.18 | 2025 | Mynxgrip |
| Bayer Healthcare Pharmaceuticals INC. | $23.26 | 2025 | |
| Merck Sharp & Dohme LLC | $20.39 | 2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $20.32 | 2019 | |
| Cardiovascular Systems INC. | $17.71 | 2019 | |
| Chiesi USA, INC. | $17.50 | 2023 | Kengreal |
| Terumo Medical Corporation | $16.71 | 2019 | |
| Asahi Intecc USA, INC. | $14.99 | 2024 | Peripheral Vascular |
| Arbor Pharmaceuticals, INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.